ClinicalTrials.Veeva

Menu

Developing Mouse Models of Breast Cancer Using Tissue Samples From Women With Breast Cancer

Vanderbilt University Medical Center logo

Vanderbilt University Medical Center

Status

Completed

Conditions

Breast Cancer

Treatments

Other: laboratory biomarker analysis
Other: medical chart review

Study type

Observational

Funder types

Other
NIH

Identifiers

NCT00897468
VU-VICC-BRE-0704
P30CA068485 (U.S. NIH Grant/Contract)
VICC BRE 0704

Details and patient eligibility

About

RATIONALE: Changing the genes in laboratory mice to create a living model of human breast cancer may help doctors learn more about breast cancer.

PURPOSE: This research study is developing mouse models of breast cancer using tissue samples that were previously collected from women with breast cancer.

Full description

OBJECTIVES:

  • To develop new in vivo models of human breast cancer.
  • To correlate response in this model to actual treatment outcome in patients, if the in vivo model is proven feasible.

OUTLINE: Previously collected breast tumor fragments are implanted into the renal capsule site of SCID mouse hosts (mouse with severe combined immune deficiency) to establish metastatic spread patterns, and both histologic and molecular tumor characteristics.

Patients' medical charts are reviewed to obtain relevant information, including general demographics, smoking and alcohol use, as well as outcome data such as survival and response to treatment.

Enrollment

26 patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

DISEASE CHARACTERISTICS:

  • Diagnosis of breast cancer

    • Any stage of disease
    • Primary or metastatic disease
  • Human breast tumor tissues available after the diagnoses have been made

  • Enrolled on the ongoing Breast Tissue Repository trial VU-VICC-BRE-03103

    • Have consented to the use of their tissues for research purpose
  • Hormone receptor status not specified

PATIENT CHARACTERISTICS:

  • Menopausal status not specified

PRIOR CONCURRENT THERAPY:

  • Not specified

Trial design

26 participants in 1 patient group

breast cancer patients
Treatment:
Other: medical chart review
Other: laboratory biomarker analysis

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems